Oramed Pharmaceuticals Inc.
Symbol: ORMP (NASDAQ)
2.42
▲ (3.86%) 0.090
Company Description:
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
Key Stats
- Today's Open: $2.34
- Today's High: $2.45
- Today's Low: $2.33
- Today's Volume: 245.59K
- Yesterday Close: $2.33
- Yesterday High: $2.33
- Yesterday Low: $2.29
- Yesterday Volume: 70.68K
- Last Min Volume: 193
- Last Min High: $2.42
- Last Min Low: $2.42
- Last Min VWAP: $2.42
Company Profile
- Name: Oramed Pharmaceuticals Inc.
- Website: https://www.oramed.com
- Listed Date: 2004-04-19
- Location: NEW YORK, NY
- Market Status: Active
- CIK Number: 0001176309
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $95.54M
- Round Lot: 100
- Outstanding Shares: 41.00M
- Asset Type: CS
RECENT FILINGS FOR ORMP
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-28 | SCHEDULE 13D/A | View |
| 2025-08-21 | S-8 | View |
| 2025-08-21 | 8-K | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-14 | 10-Q | View |
| 2025-07-23 | 8-K | View |
| 2025-07-16 | ARS | View |
| 2025-07-16 | DEF 14A | View |
| 2025-07-16 | 10-K/A | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-06-09 | 4 | View |
| 2025-05-21 | 8-K | View |
| 2025-05-15 | 10-Q | View |
| 2025-05-08 | SCHEDULE 13G/A | View |
| 2025-05-01 | SCHEDULE 13D | View |
| 2025-04-28 | 8-K | View |
| 2025-03-27 | 10-K | View |
Latest News on ORMP